Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PALM-PPF: TPIP in Progressive Pulmonary Fibrosis
NCT07805785Phase 3Recruiting
- Sponsor
- Insmed Incorporated
- Start
- Dec 2026
- Primary completion
- Aug 2030
- Countries
- 1
01
Overview
A Phase 3 trial of treprostinil palmitil in pulmonary fibrosis (PF), sponsored by Insmed Incorporated. Planned start Dec 2026; status: recruiting.
02
Drugs
treprostinil palmitil
03
Conditions
pulmonary fibrosis (PF)
Beyond the preview
Go deeper on NCT07805785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07805785.